Its remarkable to see potential anatomical brain changes one month after a single dose of any drug, said Prof Robin Carhart-Harris, a neurologist at the University of California, San Francisco, and senior author on the study
It is not approved as a personal treatment and is not intended for human consumption, self-administration, veterinary use, diagnosis, or therapeutic application
Hyperinsulinaemia in cancer
Even so, the trial design was rigorous, and the findings are consistent with what clinicians have observed in practice
You receive: Personalized dosing based on your needs Ongoing clinician support Safe and reliable administration This approach supports your weight loss journey through medically-guided and personalized care